Acrobiosystems Co.,Ltd. (SHE:301080)
China · Delayed Price · Currency is CNY 141.07
+18.07 (14.69%)
At close: Sep 30, 2026
Acrobiosystems Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 23,584 | 9,039 | 5,285 | 7,071 | 8,215 | 16,890 | |
Market Cap Growth | 140.79% | 71.05% | -25.26% | -13.93% | -51.36% | - |
Enterprise Value | 22,600 | 7,226 | 3,522 | 5,142 | 6,073 | 16,766 |
Last Close Price | 141.07 | 53.14 | 30.66 | 39.83 | 45.51 | 92.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 131.00 | 54.60 | 42.68 | 46.04 | 40.32 | 96.95 |
Forward PE | 77.94 | 32.73 | 33.67 | 31.34 | 33.13 | 75.54 |
PS Ratio | 24.82 | 10.79 | 8.19 | 13.01 | 17.32 | 43.87 |
PB Ratio | 8.87 | 3.40 | 2.02 | 2.73 | 3.20 | 6.85 |
P/TBV Ratio | 8.99 | 3.45 | 2.05 | 2.77 | 3.22 | 6.85 |
P/FCF Ratio | 180.25 | 60.00 | - | - | - | 221.35 |
P/OCF Ratio | 62.81 | 25.41 | 62.39 | 63.59 | 40.63 | 122.39 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 23.78 | 8.62 | 5.46 | 9.46 | 12.80 | 43.55 |
EV/EBITDA Ratio | 105.87 | 44.67 | 38.88 | 51.28 | 46.03 | 92.00 |
EV/EBIT Ratio | 151.33 | 61.39 | 59.22 | 65.36 | 52.21 | 96.56 |
EV/FCF Ratio | 172.74 | 47.96 | - | - | - | 219.72 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.03 | 0.03 | 0.05 | 0.03 | 0.03 | 0.01 |
Debt / EBITDA Ratio | 0.42 | 0.47 | 1.25 | 0.54 | 0.47 | 0.16 |
Debt / FCF Ratio | 0.68 | 0.57 | - | - | - | 0.39 |
Net Debt / Equity Ratio | -0.37 | -0.47 | -0.67 | -0.74 | -0.78 | -0.91 |
Net Debt / EBITDA Ratio | -5.05 | -7.78 | -19.29 | -19.17 | -15.17 | -12.34 |
Net Debt / FCF Ratio | -7.52 | -8.36 | 21.17 | 109.89 | 24.39 | -29.47 |
Asset Turnover | 0.32 | 0.28 | 0.23 | 0.20 | 0.18 | 0.28 |
Inventory Turnover | 0.62 | 0.60 | 0.59 | 0.74 | 0.76 | 0.72 |
Quick Ratio | 6.65 | 7.65 | 7.15 | 11.15 | 20.29 | 39.89 |
Current Ratio | 8.42 | 9.24 | 8.02 | 12.03 | 21.27 | 41.12 |
Return on Equity (ROE) | 6.83% | 6.26% | 4.62% | 5.72% | 7.91% | 13.01% |
Return on Assets (ROA) | 3.17% | 2.48% | 1.30% | 1.77% | 2.75% | 7.84% |
Return on Invested Capital (ROIC) | 9.27% | 10.13% | 7.47% | 11.72% | 27.50% | 98.85% |
Return on Capital Employed (ROCE) | 5.30% | 4.20% | 2.30% | 3.00% | 4.40% | 7.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.76% | 1.83% | 2.34% | 2.17% | 2.48% | 1.03% |
FCF Yield | 0.55% | 1.67% | -1.56% | -0.25% | -1.00% | 0.45% |
Dividend Yield | 0.43% | 1.13% | 1.63% | 1.61% | 1.57% | 0.77% |
Payout Ratio | 82.50% | 51.67% | 87.39% | 78.13% | 58.90% | - |
Buyback Yield / Dilution | 0.35% | 0.22% | 0.08% | 0.04% | -26.35% | -5.55% |
Total Shareholder Return | 0.77% | 1.35% | 1.71% | 1.66% | -24.78% | -4.78% |